These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24841217)

  • 1. Comprehensive molecular characterisation of hereditary non-polyposis colorectal tumours with mismatch repair proficiency.
    Bellido F; Pineda M; Sanz-Pamplona R; Navarro M; Nadal M; Lázaro C; Blanco I; Moreno V; Capellá G; Valle L
    Eur J Cancer; 2014 Jul; 50(11):1964-72. PubMed ID: 24841217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased frequency of 20q gain and copy-neutral loss of heterozygosity in mismatch repair proficient familial colorectal carcinomas.
    Middeldorp A; van Eijk R; Oosting J; Forte GI; van Puijenbroek M; van Nieuwenhuizen M; Corver WE; Ruano D; Caldes T; Wijnen J; Morreau H; van Wezel T
    Int J Cancer; 2012 Feb; 130(4):837-46. PubMed ID: 21445971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer.
    Loughrey MB; Waring PM; Tan A; Trivett M; Kovalenko S; Beshay V; Young MA; McArthur G; Boussioutas A; Dobrovic A
    Fam Cancer; 2007; 6(3):301-10. PubMed ID: 17453358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methylation changes and somatic mutations as tumorigenic events in Lynch syndrome-associated adenomas retaining mismatch repair protein expression.
    Mäki-Nevala S; Valo S; Ristimäki A; Sarhadi V; Knuutila S; Nyström M; Renkonen-Sinisalo L; Lepistö A; Mecklin JP; Peltomäki P
    EBioMedicine; 2019 Jan; 39():280-291. PubMed ID: 30578081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.
    Carethers JM; Stoffel EM
    World J Gastroenterol; 2015 Aug; 21(31):9253-61. PubMed ID: 26309352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial colorectal cancer type X syndrome: two distinct molecular entities?
    Francisco I; Albuquerque C; Lage P; Belo H; Vitoriano I; Filipe B; Claro I; Ferreira S; Rodrigues P; Chaves P; Leitão CN; Pereira AD
    Fam Cancer; 2011 Dec; 10(4):623-31. PubMed ID: 21837511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of tumour BRAF mutations and MLH1 methylation with germline mismatch repair (MMR) gene mutation status: a literature review assessing utility of tumour features for MMR variant classification.
    Parsons MT; Buchanan DD; Thompson B; Young JP; Spurdle AB
    J Med Genet; 2012 Mar; 49(3):151-7. PubMed ID: 22368298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency.
    Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T
    Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular analysis of colorectal cancer tumors from patients with mismatch repair proficient hereditary nonpolyposis colorectal cancer suggests novel carcinogenic pathways.
    Sánchez-de-Abajo A; de la Hoya M; van Puijenbroek M; Tosar A; López-Asenjo JA; Díaz-Rubio E; Morreau H; Caldes T
    Clin Cancer Res; 2007 Oct; 13(19):5729-35. PubMed ID: 17908962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered methylation at microRNA-associated CpG islands in hereditary and sporadic carcinomas: a methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA)-based approach.
    Pavicic W; Perkiö E; Kaur S; Peltomäki P
    Mol Med; 2011; 17(7-8):726-35. PubMed ID: 21327300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter hypermethylation frequency and BRAF mutations distinguish hereditary non-polyposis colon cancer from sporadic MSI-H colon cancer.
    McGivern A; Wynter CV; Whitehall VL; Kambara T; Spring KJ; Walsh MD; Barker MA; Arnold S; Simms LA; Leggett BA; Young J; Jass JR
    Fam Cancer; 2004; 3(2):101-7. PubMed ID: 15340260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A population-based study of hereditary non-polyposis colorectal cancer: evidence of pathologic and genetic heterogeneity.
    Warden G; Harnett D; Green J; Wish T; Woods MO; Green R; Dicks E; Rahman P; Zhai G; Parfrey P
    Clin Genet; 2013 Dec; 84(6):522-30. PubMed ID: 23278430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.
    Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A
    J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct patterns of KRAS mutations in colorectal carcinomas according to germline mismatch repair defects and hMLH1 methylation status.
    Oliveira C; Westra JL; Arango D; Ollikainen M; Domingo E; Ferreira A; Velho S; Niessen R; Lagerstedt K; Alhopuro P; Laiho P; Veiga I; Teixeira MR; Ligtenberg M; Kleibeuker JH; Sijmons RH; Plukker JT; Imai K; Lage P; Hamelin R; Albuquerque C; Schwartz S; Lindblom A; Peltomaki P; Yamamoto H; Aaltonen LA; Seruca R; Hofstra RM
    Hum Mol Genet; 2004 Oct; 13(19):2303-11. PubMed ID: 15294875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longer telomeres are associated with cancer risk in MMR-proficient hereditary non-polyposis colorectal cancer.
    Seguí N; Guinó E; Pineda M; Navarro M; Bellido F; Lázaro C; Blanco I; Moreno V; Capellá G; Valle L
    PLoS One; 2014; 9(2):e86063. PubMed ID: 24498269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
    Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
    Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microsatellite instability: application in hereditary non-polyposis colorectal cancer.
    Saletti P; Edwin ID; Pack K; Cavalli F; Atkin WS
    Ann Oncol; 2001 Feb; 12(2):151-60. PubMed ID: 11300317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and clinicopathological characteristics of mismatch repair-deficient colorectal carcinoma in early onset cases as compared with late-onset cases: a retrospective cross-sectional study in Northeastern Iran.
    Goshayeshi L; Ghaffarzadegan K; Khooei A; Esmaeilzadeh A; Rahmani Khorram M; Mosannen Mozaffari H; Kiani B; Hoseini B
    BMJ Open; 2018 Aug; 8(8):e023102. PubMed ID: 30166308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early genetic aberrations in patients with sporadic colorectal cancer.
    Druliner BR; Ruan X; Sicotte H; O'Brien D; Liu H; Kocher JA; Boardman L
    Mol Carcinog; 2018 Jan; 57(1):114-124. PubMed ID: 28926134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double somatic mutations in mismatch repair genes are frequent in colorectal cancer after Hodgkin's lymphoma treatment.
    Rigter LS; Snaebjornsson P; Rosenberg EH; Atmodimedjo PN; Aleman BM; Ten Hoeve J; Geurts-Giele WR; ; van Ravesteyn TW; Hoeksel J; Meijer GA; Te Riele H; van Leeuwen FE; Dinjens WN; van Leerdam ME
    Gut; 2018 Mar; 67(3):447-455. PubMed ID: 29439113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.